End-to-end encryption and privacy controls.
Message and call for free* around the world.
Group conversations made simple.
Say it with stickers, voice, GIFs and more.
Reach your customers from anywhere.
禮來阿茲海默氏症 Solanezumab 三期試驗失敗,主要與次要終點皆未達標 https://geneonline.news/lilly-solanezumab-alzheimers/